Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Dexmedetomidine
The First People's Hospital of Lianyungang
Overall Survival
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Elderly
3 trials -
Dexmedetomidine
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Dexmedetomidine
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Dexmedetomidine
The University of Hong Kong
Anxiety, Separation
1 trial -
Dexmedetomidine
BioXcel Therapeutics
Schizophrenia Agitation
1 trial -
Dexmedetomidine-esketamine combination
The First People's Hospital of Lianyungang
Obstructive Sleep Apnea
1 trial -
Diane-35 pretreatment
The First People's Hospital of Lianyungang
Polycystic Ovary Syndrome
1 trial -
Doxorubicin Accord 2 mg/ml koncentrat till infusionsvätska, lösning, Paclitaxel Accord 6 mg/ml koncentrat till infusionsvätska, lösning, Docetaxel Ebewe 10 mg/ml koncentrat till infusionsvätska, lösning, Epirubicin Accord 2 mg/ml injektions-/infusionsvätska, lösning, Sendoxan pulver till injektionsvätska, lösning
The George Institute
Breast cancer female NOS
1 trial -
Drawtex dressing
United Therapeutics Europe Ltd
Pilonidal Disease
1 trial -
Dual chamber pacemeker
Rhythm Pharmaceuticals Netherlands B.V.
Syncope
1 trial -
ELEVIDYS
Sarepta Therapeutics
Duchenne Muscular Dystrophy
1 trial -
ENDORET-PRGF
The George Institute
pterygium
1 trial -
ESTRIOL , ESTRADIOL HEMIHYDRATE, PROMESTRIENE, PROGESTERONE, ESTRADIOL VALERATE
The George Institute
Cervical cancer
1 trial -
ETHINYL ESTRADIOL AND LEVOGESTREL
United Therapeutics Europe Ltd
HIV/AIDS
1 trial -
Edaravone dexborneol
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Eliquis 5 mg film-coated tablets, Waran 2,5 mg tabletter, OPTISON 0.19 mg/ml dispersion for injection, SonoVue 8 microlitres/mL powder and solvent for dispersion for injection, Eliquis 2.5 mg film-coated tablets
The George Institute
Left ventricular thrombosis., Acute mycocardial infarction (AMI)
1 trial -
Elucirem 0.5 mmol/mL solution for injection, Gadovist 1.0 mmol/ml solution for injection in prefilled cartridge
The George Institute
Perianal fistula associated with Crohn's disease
1 trial -
Enoxaparin 40 mg q12h
United Therapeutics Europe Ltd
Traumatic Injury
1 trial -
Epoetin Alfa
United Therapeutics Europe Ltd
Exercise-Induced Anemia
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Scoliosis Correction
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Postpartum Depression
1 trial -
Esketamine 0.2 mg/kg
The First People's Hospital of Lianyungang
Cesarean Delivery
1 trial -
Esketamine 1
The First People's Hospital of Lianyungang
Elderly
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources